Clinical Trial Update: Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of multiple doses of ISIS-SGLT2Rx in healthy volunteers, with exploratory activity assessments related to Type 2 Diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ISIS-SGLT2Rx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED